Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119062) titled 'Efficacy and Safety of Fractional Er:YAG Laser Combined with Halometasone and Triclosan Cream in the Treatment of Keloids: A Randomized Controlled Clinical Trial' on Feb. 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
keloid
Intervention:
Group A:Group A: 2940nm Fractional Er:YAG Laser combined with Halometasone and Triclosan Cream
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-02-15
Target Sample Size: Group A:30;Group B:30;
Countries of Recruitment:
China
To know more, visit h...